160 related articles for article (PubMed ID: 7825064)
21. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole SP; Sparks KE; Fraser K; Loe DW; Grant CE; Wilson GM; Deeley RG
Cancer Res; 1994 Nov; 54(22):5902-10. PubMed ID: 7954421
[TBL] [Abstract][Full Text] [Related]
22. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function.
Chen ZS; Aoki S; Komatsu M; Ueda K; Sumizawa T; Furukawa T; Okumura H; Ren XQ; Belinsky MG; Lee K; Kruh GD; Kobayashi M; Akiyama S
Int J Cancer; 2001 Jul; 93(1):107-13. PubMed ID: 11391629
[TBL] [Abstract][Full Text] [Related]
23. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
24. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance.
Heenan M; O'Driscoll L; Cleary I; Connolly L; Clynes M
Int J Cancer; 1997 May; 71(5):907-15. PubMed ID: 9180164
[TBL] [Abstract][Full Text] [Related]
25. The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
Utz I; Hofer S; Regenass U; Hilbe W; Thaler J; Grunicke H; Hofmann J
Int J Cancer; 1994 Apr; 57(1):104-10. PubMed ID: 7908658
[TBL] [Abstract][Full Text] [Related]
26. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC
Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558
[TBL] [Abstract][Full Text] [Related]
27. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
[TBL] [Abstract][Full Text] [Related]
28. Establishment and characterization of renal cell carcinoma cell lines with multidrug resistance.
Yu DS; Ma CP; Chang SY
Urol Res; 2000 Apr; 28(2):86-92. PubMed ID: 10850629
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
Long BH; Wang L; Lorico A; Wang RC; Brattain MG; Casazza AM
Cancer Res; 1991 Oct; 51(19):5275-83. PubMed ID: 1717144
[TBL] [Abstract][Full Text] [Related]
30. Emergence of different mechanisms of resistance in the evolution of multidrug resistance in murine erythroleukemia cell lines.
Modrak DE; Draper MP; Levy SB
Biochem Pharmacol; 1997 Dec; 54(12):1297-306. PubMed ID: 9393672
[TBL] [Abstract][Full Text] [Related]
31. Reversal of P-glycoprotein mediated multidrug resistance by a newly synthesized 1,4-benzothiazipine derivative, JTV-519.
Che XF; Nakajima Y; Sumizawa T; Ikeda R; Ren XQ; Zheng CL; Mukai M; Furukawa T; Haraguchi M; Gao H; Sugimoto Y; Akiyama S
Cancer Lett; 2002 Dec; 187(1-2):111-9. PubMed ID: 12359358
[TBL] [Abstract][Full Text] [Related]
32. Establishment of new multidrug-resistant human osteosarcoma cell lines.
Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
[TBL] [Abstract][Full Text] [Related]
33. Activation of silent MDR1 genes in revertant cells by fusion with multidrug-resistant cells.
Yusa K; Tamura J; Waki A; Tsuruo T
Biochim Biophys Acta; 1995 Nov; 1269(3):260-6. PubMed ID: 7495879
[TBL] [Abstract][Full Text] [Related]
34. Reversal effect of BM-cyclin 1 on multidrug resistance in C-A120 cells.
Wang L; Sun J; Li YQ; Chen ZS; Akiyama S; Xian LJ
Anticancer Drugs; 2007 Oct; 18(9):1015-21. PubMed ID: 17704651
[TBL] [Abstract][Full Text] [Related]
35. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.
Shiraishi N; Akiyama S; Nakagawa M; Kobayashi M; Kuwano M
Cancer Res; 1987 May; 47(9):2413-6. PubMed ID: 3567927
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy.
Gouazé V; Yu JY; Bleicher RJ; Han TY; Liu YY; Wang H; Gottesman MM; Bitterman A; Giuliano AE; Cabot MC
Mol Cancer Ther; 2004 May; 3(5):633-9. PubMed ID: 15141021
[TBL] [Abstract][Full Text] [Related]
37. Increased phosphorylation of DNA topoisomerase II in etoposide resistant mutants of human glioma cell line.
Matsumoto Y; Kunishio K; Nagao S
J Neurooncol; 1999; 45(1):37-46. PubMed ID: 10728908
[TBL] [Abstract][Full Text] [Related]
38. Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs.
Osborn MT; Chambers TC
J Biol Chem; 1996 Nov; 271(48):30950-5. PubMed ID: 8940082
[TBL] [Abstract][Full Text] [Related]
39. Resistance to topoisomerase II inhibitors in human glioma cell lines overexpressing multidrug resistant associated protein (MRP) 2.
Matsumoto Y; Tamiya T; Nagao S
J Med Invest; 2005 Feb; 52(1-2):41-8. PubMed ID: 15751272
[TBL] [Abstract][Full Text] [Related]
40. Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin.
Krishnamachary N; Ma L; Zheng L; Safa AR; Center MS
Oncol Res; 1994; 6(3):119-27. PubMed ID: 7994083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
